Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Accumulated deficit	Total
Balance at beginning of period at Dec. 31, 2024		$ 720,488	$ 8	$ (659,235)	$ 61,261
Balance at beginning of period (in shares) at Dec. 31, 2024	3,161,503
Stockholders' equity
Exercise of stock options and vesting of restricted stock units (in shares)	14,325
Unrealized gain (loss) on marketable securities			$ (8)		(8)
Issuance of shares in connection with employee stock purchase plan		14			14
Issuance of shares in connection with employee stock purchase plan (in shares)	2,882
Share-based compensation expense		1,781			1,781
Net loss				(24,790)	(24,790)
Balance at end of period at Jun. 30, 2025		722,283		(684,025)	38,258
Balance at end of period (in shares) at Jun. 30, 2025	3,178,710
Balance at beginning of period at Mar. 31, 2025		721,346		(674,640)	46,706
Balance at beginning of period (in shares) at Mar. 31, 2025	3,165,828
Stockholders' equity
Exercise of stock options and vesting of restricted stock units (in shares)	10,000
Issuance of shares in connection with employee stock purchase plan		14			14
Issuance of shares in connection with employee stock purchase plan (in shares)	2,882
Share-based compensation expense		923			923
Net loss				(9,385)	(9,385)
Balance at end of period at Jun. 30, 2025		722,283		(684,025)	38,258
Balance at end of period (in shares) at Jun. 30, 2025	3,178,710
Balance at beginning of period at Dec. 31, 2025		723,512		(704,757)	18,755
Balance at beginning of period (in shares) at Dec. 31, 2025	3,182,810
Stockholders' equity
Exercise of stock options and vesting of restricted stock units (in shares)	35,000
Share-based compensation expense		1,081			1,081
Net loss				(15,380)	(15,380)
Balance at end of period at Jun. 30, 2026		724,593		(720,137)	4,456
Balance at end of period (in shares) at Jun. 30, 2026	3,217,810
Balance at beginning of period at Mar. 31, 2026		724,068		(712,316)	11,752
Balance at beginning of period (in shares) at Mar. 31, 2026	3,207,810
Stockholders' equity
Exercise of stock options and vesting of restricted stock units (in shares)	10,000
Share-based compensation expense		525			525
Net loss				(7,821)	(7,821)
Balance at end of period at Jun. 30, 2026		$ 724,593		$ (720,137)	$ 4,456
Balance at end of period (in shares) at Jun. 30, 2026	3,217,810